Citation sources

Updated weekly. Details via Crossref

Crossref	Scopus	Google Scholar
8	8	Search

2025	Risk of manic switch and suicidal outcomes in bipolar depression treated with esketamine: A one-year retrospective cohort study of 2126 patients European Neuropsychopharmacology Ting-Hui Liu, Jheng-Yan Wu, Po-Yu Huang, Wan-Lin Cheng, Chih-Cheng Lai
2025	Body mass index is associated with the antidepressant effects of intravenous ketamine in patients with depression Frontiers in Psychiatry Jian-Qiang Tan, Li-Mei Gu, Yan-Ling Zhou, Cheng-Yu Wang, Xiao-Feng Lan, Wei Zheng, Yu-Ping Ning
2025	New Agents in the Treatment of Psychiatric Disorders: What Innovations and in What Areas of Psychopathology? Pharmaceuticals Paola Bozzatello, Roberta Novelli, Rebecca Schisano, Claudio Brasso, Paola Rocca, Silvio Bellino
2022	Comparative effectiveness of repeated ketamine infusions in treating anhedonia in bipolar and unipolar depression Journal of Affective Disorders Wei Zheng, Li-Mei Gu, Chen-Hui Sun, Yan-Ling Zhou, Cheng-Yu Wang, Xiao-Feng Lan, Bin Zhang, Yu-Ping Ning
2022	Treatment-Resistant Bipolar Depression: Therapeutic Trends, Challenges and Future Directions Neuropsychiatric Disease and Treatment Omar H Elsayed, Mete Ercis, Mehak Pahwa, Balwinder Singh
2022	Antianhedonic effects of serial intravenous subanaesthetic ketamine in anxious versus nonanxious depression Journal of Affective Disorders Wei Zheng, Xin-Hu Yang, Li-Mei Gu, Jian-Qiang Tan, Yan-Ling Zhou, Cheng-Yu Wang, Yu-Ping Ning
2021	The potential pro-cognitive effects with intravenous subanesthetic ketamine in adults with treatment-resistant major depressive or bipolar disorders and suicidality Journal of Psychiatric Research Yanling Zhou, Chengyu Wang, Xiaofeng Lan, Wei Zheng, Hanqiu Li, Ziyuan Chao, Kai Wu, Roger S. McIntyre, Yuping Ning
2021	Contemporary Clinical Neuroscience Yunfei Tan, Kenji Hashimoto